-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s stock price fell 1.5% during mid-day trading on Wednesday . The company traded as low as $6.23 and last traded at $6.40. 914,451 shares traded hands during trading, a decline of 73% from the average session volume of 3,376,665 shares. The stock had previously closed at $6.50.
Mind Medicine (MindMed) Stock Performance
The firm’s fifty day moving average price is $7.44 and its 200 day moving average price is $6.94.
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Featured Articles
- Five stocks we like better than Mind Medicine (MindMed)
- What is the S&P 500 and How It is Distinct from Other Indexes
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Election Stocks: How Elections Affect the Stock Market
- How Do Stock Buybacks Affect Shareholders?
- How Can Investors Benefit From After-Hours Trading
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
